We have previously demonstrated increased IFN‐I signaling and serum IFN‐α levels in early rheumatoid arthritis (eRA) with negative prognostic implications on initial disease control and clinical outcomes.4, 5. This evidence concerns the gene IFNA2 and rheumatoid arthritis.